NEW YORK, Feb. 25 (UPI) -- Pfizer Inc. in New York said the trial of its pneumonia immunization in adults age 65 and older against bacterial pneumonia achieved its goals. The Community-Acquired Pneumonia Immunization Trial in Adults, the ...
It's still not too late to get a flu shot, the U.S. Food and Drug Administration said Wednesday. Flu activity often peaks in January or February and can last well into May, and a flu shot protects you as long as flu viruses are ...
Tags: flu shot, circulating viruses, drug
The prevalence of a painful condition known as shingles is increasing in the United States, but new research says the chickenpox vaccine isn't to blame. Shingles is caused by the same virus that causes chickenpox, the varicella zoster ...
Tags: shingles, chickenpox vaccine, varicella zoster virus, health
GlaxoSmithKline (GSK) is mulling to establish a joint venture (JV) with a Chinese company as part of its vaccine strategy of teaming up with local partners. The plans come at a time when the company is facing corruption and tax laws ...
Tags: Vaccine Research, GSK
Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...
Tags: Pneumococcal Vaccine, Medicine
The Vaccine World Summit India 2013 conference has honored Novavax, Cadila Pharmaceuticals Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) collaboration for having the 'most promising ...
Tags: malaria vaccine, Pharmaceuticals, Vaccine
Pfizer has obtained the European Commission approval for the use of Prevenar 13 vaccine in older children and adolescents aged six to 17 years for the prevention of pneumococcal disease. Single dose of the pneumococcal conjugate vaccine ...
Tags: vaccine, Pfizer, pneumococcal disease, medicines